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146 The Journal of Thoracic and CardioObjective: A new mechanical anastomotic device was evaluated, aiming at its future
use in minimally invasive techniques or limited access surgery in patients under-
going coronary artery bypass grafting.
Methods: Between April and December 2002, a total of 60 patients scheduled for
elective multivessel bypass grafting were randomly assigned. One vein graft–coronary
artery anastomosis per patient was either performed with the St Jude Medical ATG
coronary connector system (n 30; St Jude Medical Inc, St Paul, Minn) or hand sewn
(n  30). Selective coronary angiography or coronary magnetic resonance imaging of
the studied graft and vessel was included in the 6-month follow-up.
Results: Twenty-eight of the connectors were successfully implanted. Two patients
were excluded from the study because of conversion to hand-sewn anastomoses. Six
connector-made anastomoses were bleeding at the anastomotic site. At the time of
follow-up (190 postoperative days), all control anastomoses and grafts were patent,
whereas 26% of the connector anastomoses were occluded. One graft in each group
was patent but with stenosis.
Conclusion: The St Jude Medical ATG coronary connector system for distal anas-
tomoses represents a new concept for sutureless anastomoses in cardiac surgery.
This randomized, controlled study shows lower graft patency for anastomoses
performed with the connector than for hand-sewn control anastomoses. It illustrates
the importance of controlled studies when evaluating new technical equipment in
medicine.
The most common and effective way of creating an anastomosisbetween grafts and the aorta or coronary arteries in coronary arterybypass grafting (CABG) is by a running hand-sewn suture withnonresorbable material. However, the success of this technique isdependent on various factors related to surgical experience and skill.During the past decade, a rapid development in off-pump CABG has
made the exposure and visualization of all aspects of the heart possible, thereby
creating the potential for less invasive techniques. In parallel, a need for semiau-
tomatic anastomosing devices has grown.
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has developed a family of connectors for both proximal
(vein grafts to the aorta)1-3 and distal (vein grafts to the
coronary artery)4 anastomoses. Recently, Eckstein and col-
leagues5,6 demonstrated the feasibility of using the new
coronary connector for distal anastomoses in CABG. To
investigate the St Jude Medical stainless steel 2.0 distal
connector (St Jude Medical ATG coronary connector; St
Jude Medical Inc, St Paul, Minn), we designed a prospec-
tive, randomized study. Patients were studied regarding
cardiac events and graft patency 6 months after CABG.
Material and Methods
The protocol of this study was reviewed and approved by the local
ethical committee of The University of Göteborg (Göteborg, Swe-
den; approval S 263-01, Aug 7, 2001). Informed consent for a
single mechanical vein-to-coronary connection was obtained from
each patients. The protocol of the study was also reviewed and
approved by the Medical Product Agency (Uppsala,
Sweden; approval 461:2001/046032).
The coronary connector was used for a single anastomosis in
each patient. Inclusion criteria required a coronary outer diameter
greater than 2.5 mm at the anastomotic site, corresponding to an
estimated inner diameter greater than 2.0 mm. The vein graft’s
internal diameter had to exceed 3.5 mm. The random assignment
took place at the time of inspection and measurement of the target
vessel. In the preoperative angiographic screening, care was taken
to choose patients with comparable distributions of target vessels
in the two groups. Patients were excluded for the following crite-
ria: emergency procedures, reoperative CABG, recent neurologic
events, significant comorbidities (such as peripheral vascular dis-
ease, renal insufficiency, severe chronic obstructive pulmonary
disease), left ventricular ejection fraction less than 25%, pregnancy
or nursing, and requirement of chronic anticoagulation other than
acetylsalicylic acid in the postoperative period.
All procedures were performed according to our standard pro-
tocol with extracorporeal circulation (ECC) and cold blood car-
dioplegia. After harvest of the saphenous vein, the external diam-
eter of the graft was assessed to ensure compliance with the
connector system. When the patient was randomly assigned to
receive a connector-created anastomosis, the vein was loaded onto
the stainless steel clip system, which consisted of an implantable
connector, a delivery system, a vessel-loading tool and transfer
sheath, a venotomy and arteriotomy tool, and an artery and vein–
dilating tool. The loading procedure was as follows: the connector
was mounted on the delivery system as shown (Figure 1). The
vessel-loading sheath was advanced into the distal end of the vein
graft. The vessel-loading sheath supported the graft while an
aperture was dilated in the side wall of the graft at the anastomotic
site. The delivery system was then passed through the lumen of the
vessel-loading sheath until the nose cone was advanced out
through the aperture created in the side wall of the graft. The
connector and delivery system were then ready for deployment
into the target site (Figure 2). After pressurization of the coronary
artery by blood cardioplegia, a small transverse incision at the
target coronary artery was made with a small arteriotomy blade
and dilated with a standardized dilating tool. The delivery system
The Journal of Thoraciwas then introduced into the coronary artery until it was in contact
with the coronary artery wall (Figure 3). With the device in place,
the nose cone was advanced to uncover the internal fingers, and the
delivery system was then positioned at 90° with respect to the
coronary artery. The balloon was then inflated, expanding the clip
(Figure 4). Once the clip was expanded, the delivery system was
deflated and removed, and the vessel graft was ligated immediately
distal to the anastomosis without compromising the vessel-anas-
tomosis lumen (Figure 5). After completion of the distal anasto-
mosis with the connector system, the subsequent operation was
done as a standard procedure.
Intraoperative graft blood flow was measured with a transit
time flowmeter (Medi-Stim AS, Oslo, Norway) in all studied grafts
after weaning from ECC. All patients received acetylsalicylic acid
(160 mg) daily starting on postoperative day 1, according to our
clinical routine at that time. Six months after CABG, the patients
were examined regarding physical status and chest pain and any
cardiac or adverse events were registered. A selective coronary
angiography of the studied anastomosed vessel was scheduled for
the same time. A complete coronary angiography was performed if
the patient had reported symptoms of chest pain. If the patients
refused coronary angiography, coronary magnetic resonance im-
aging (MRI) was offered instead. Furthermore, 7 patients with
occluded grafts on angiography were also examined with coronary
MRI to verify the angiographic finding.
Results
Between April and December 2002, a total of 60 patients
scheduled for elective first-time multivessel CABG were
randomly assigned to receive either a hand-sewn vein graft–
coronary artery anastomosis (n  30) or a vein graft–
coronary artery anastomosis performed with the St Jude
Medical ATG coronary connector system. There were no
significant differences between groups regarding preopera-
tive demographic data (Table 1). One patient was excluded
because of a plaque in the back wall, resulting in dislocation
of the connector, and the anastomosis was eventually hand
sewn. In another patient, the connector was successfully
deployed but the graft was too short. The graft was ex-
changed and hand sewn. Six connector-made anastomoses
were leaking from the anastomotic site, requiring one addi-
tional suture each with 7-0 polypropylene suture (Prolene;
Ethicon, Inc, Somerville, NJ). One patient in the control
group died on postoperative day 6 in arrhythmia. Another
patient in the control group had a stroke develop early in the
postoperative period. One patient who received a connector-
created anastomosis underwent reoperation for bleeding,
but no bleeding source was found at the anastomotic site.
All patients received complete revascularization (mean
number of distal anastomoses 3  0.7). Fifty-eight patients
received an internal thoracic artery to the left anterior de-
scending coronary artery. The target vessels of the studied
grafts are shown in Table 2. The mean time required to load
the vein graft onto the delivery system was 135  11
seconds, and the time for deploying the connector was less
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weaning from ECC were a mean of 47  8 mL/min in the
connector group and a mean of 46  4 mL/min in the
control group, indicating that all anastomoses were patent at
the end of the procedure. The mean ECC times were 65 
4 minutes in the connector group and 59  3 minutes in the
control group. There were no differences in mean ischemic
time between the connector and the control group (37  2
and 35  2 minutes, respectively). At the 6-month follow-
up, 59 patients had had no chest pain or cardiac-related
adverse events. One patient had chest pain 3 months after
the operation, and coronary angiography revealed an oc-
cluded graft to the right coronary artery (not a studied graft)
and a significant stenosis at the connector-made anastomo-
sis to an obtuse marginal branch. The patient underwent
reoperation through a left thoracotomy, receiving a vein
graft between the descending aorta and the obtuse marginal
branch. The anastomosis to the descending aorta was per-
formed with the St Jude Medical proximal connector (Sym-
metry; St Jude Medical Inc), which facilitated the anasto-
motic procedure in the deep wound.
Fifty-seven patients were scheduled for a 6-month fol-
low-up with either coronary angiography or MRI (2 patients
were excluded because of conversion to hand-sewn anasto-
moses and 1 patient had died). Coronary angiography was
performed 179 days after CABG in 46 patients (23 in each
Figure 1. Schematic illustration of loaded vein on delivery system
introduced into coronary artery. (Reprinted with permission of
St Jude Medical, Inc, St Paul, Minn.)
Figure 2. Schematic illustration of connector and delivery system
ready for deployment into target vessel. (Reprinted with permis-
sion of St Jude Medical, Inc, St Paul, Minn.)group). MRI was performed 255 days after CABG in 8
148 The Journal of Thoracic and Cardiovascular Surgery ● Janupatients (4 in each group). Three patients (5.3%) were
unavailable for follow-up; 1 in the connector group who had
moved abroad and 2 patients in the control group who were
Figure 3. Schematic illustration of connector and delivery system
introduced into target vessel. (Reprinted with permission of
St Jude Medical, Inc, St Paul, Minn.)
Figure 4. Inflation of balloon and expansion of clip. (Reprinted
with permission of St Jude Medical, Inc, St Paul, Minn.)
Figure 5. Schematic illustration of completed side-to-side anas-
tomosis. (Reprinted with permission of St Jude Medical, Inc,
St Paul, Minn.)doing well but refused both coronary angiography and MRI.
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of the grafts performed with the connector were occluded
(26%), as verified by both coronary angiography and MRI.
One patient in each group had a significant stenosis at the
anastomotic site (Table 3). Of the 7 occluded grafts, 3
required an extra suture because of bleeding.
Discussion
There are several reasons for the vast interest in developing
new technology for vascular connections. With the increas-
ing popularity of beating-heart CABG, the need to develop
the anastomotic technique increases. The final goal for this
technique is the use of a simple mechanical anastomotic
device inserted through a small skin incision. Now that
percutaneous coronary interventions are developing rapidly,
it is important to simplify the CABG procedure to make it
more appealing for both the referring cardiologist and the
patient, especially in the light of the good long-term results
of the CABG procedure. There is also an industrial interest
in the profit of developing new products in new fields of
medicine.
A limitation of this study lies in its variability among the
individual patients. Size of the coronary arteries, morpho-
logic and pathologic properties of the arterial wall, and other
factors differ among patients however well they are chosen.
A larger random sample of patients would reduce this
phenomenon; however, in the light of our results it would
raise ethical objections.
The rather strict selection of patients with regard to
exclusion criteria was based on our efforts to limit varia-
tions among patients and also to avoid possible effects of




Male/female ratio 57:3 51:9
Age (y, mean and range) 69 (43-83) 67 (42-81)
Hypertension (No.) 19 (63%) 13 (43%)
Diabetes (No.) 6 (20%) 9 (30%)
History of smoking (No.) 12 (40%) 12 (40%)
Stroke or transient ischemic attack (No.) 4 (13%) 2 (7%)
Hyperlipidemia (No.) 16 (53%) 12 (40%)
Chronic obstructive pulmonary disease
(No.)
— 3 (10%)
New York Heart Association functional
class (No.)
I 23 (77%) 26 (87%)
II 4 (13%) 1 (3%)
III 2 (7%) 2 (7%)
Myocardial infarction (No.) 14 (47%) 12 (33%)
Peripheral vascular disease (No.) — 4 (13%)
Percutaneous coronary intervention (No.) — 1 (3%)medication on grafts and coronaries. Low ejection fraction,
The Journal of Thoracireoperative procedures, and emergency surgery were con-
sidered as complicating factors when trying out this new
equipment and were therefore avoided.
Several anastomotic devices based on different tech-
niques have been presented for trial and testing on coronary
arteries.7-11 In this study, the St Jude Medical stainless steel
2.0 distal connector had an early graft patency of 76%,
which could be regarded as an acceptable result compared
with early graft patency in vein grafts.12 Compared with the
control group in this study, however, in which all hand-
sewn grafts were open, it is not acceptable. This stresses the
importance of study design early in the developmental pro-
cess of new technology to get relevant information. It is of
utmost importance not only for the patient but also for the
industry to get accurate information from clinical and sci-
entifically correct studies.
Because the outer diameter of the target vessels in this
study had to be greater than 2.5 mm and the coronary
arteries were required to be without too much calcification,
there was a clear selection of lightly diseased vessels, in
which graft patency of sutured anastomoses can be expected
to be high as found in the control group. There could be
several reasons for the occlusions of the connector-made
anastomoses. Foreign material is introduced into the intima
of the vessels and might induce intimal hyperplasia, which
has been described after intracoronary stent placement.13
This phenomenon has not been observed in long-term ani-
mal studies with coronary connectors; however, in those
studies the device was introduced in a healthy area. Borst
and associates14 presented a study in which the foreign
material exposed in the lumen with different stents and
TABLE 2. Distribution of target vessels (studied grafts)
Connector Hand sewn
Obtuse marginal branch I 10 11
Obtuse marginal branch II 2 2
Right coronary artery 2 2
Posterior descending artery 7 9
First diagonal artery 1 4
Second diagonal artery 2 1
Intermediate artery 4 1
Total 28 30
TABLE 3. Postoperative graft findings at coronary angiog-
raphy or coronary MRI
Connector Hand sewn
Patent 20 (74%) 27 (100%)
Occluded 7 (26%) 0
Total 27 27coupling devices was quantified. The St Jude Medical con-
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of foreign material exposed in the lumen, which makes this
explanation less probable.
In our study, postoperative prophylaxis was attempted
with acetylsalicylic acid only, according to our clinical
routine after CABG at that time. It has been known for some
time that the results after percutaneous coronary interven-
tions have been improved with administration of clopi-
dogrel,15,16 a drug with a wider and more complex effect on
platelets. Considering our results, it can be discussed
whether a more effective prophylaxis should have been
used, along the lines of the routines used by percutaneous
coronary interventionalists, but the question then arises as to
whether to treat the control group as well, introducing an
ethical aspect because clopidogrel is not a drug recom-
mended after CABG in this country.
There could also be a mechanical reason for the occlu-
sion of the connector-made anastomoses. After deployment
of the connector, the vein has to be ligated, which creates a
sac close to the anastomotic site in which a thrombus
eventually will form. Studies have shown a remodeling of
the intimal layer in such a sac as a result of the flow pattern.
In 6 connector-made anastomoses, an extra suture was
placed at the anastomotic site to mobilize the adventitia and
achieve a padding effect to stop ongoing bleeding. Even if
the removal of a failing connector is feasible, the coronary
artery will be traumatized, which will jeopardize the quality
of the subsequent anastomosis. In the situation of a technical
failure, such as a leaking anastomosis, we chose to add a
suture carefully instead of anastomosing a damaged target
vessel. In 3 of 7 occluded grafts, an extra suture had been
placed for that reason. In 4 cases with occluded grafts,
however, the deployment of the connectors was uneventful,
indicating that an extra suture was not the only plausible
cause of occlusion. The complexity of the whole connector
system, in addition to biologic variations (graft and coro-
nary quality, wall thickness, or a mismatch between the vein
graft and coronary artery) may strongly contribute to the
leakage. Another cause for leakage could be a deformation
of the stainless steel connector during the deployment. This
weakness could probably be avoided by using another ma-
terial, such as nitinol.
Eckstein and colleagues6 recently reported only 1 oc-
cluded graft out of 11 at 3 postoperative months in anasto-
moses created with the St Jude Medical coronary connector.
There could be several explanations for this discrepancy in
results. They observed narrowing at the anastomotic sites in
3 cases, which could be interpreted as thrombus under
formation. They were also using a larger connector, 2.5
rather than 2.0. In comparing their data with ours, we
consider it a great challenge to construct connectors aimed
150 The Journal of Thoracic and Cardiovascular Surgery ● Janufor vessels smaller than 2.5 mm with an acceptable occlu-
sion rate.
In conclusion, the St Jude Medical ATG coronary 2.0
connector is not ready for clinical use. There is too high an
incidence of leakage, and the graft patency is too low. This
finding illustrates the importance of controlled studies when
evaluating new technical equipment in medicine.
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